Markets and policy challenges in access to essential medicines for endemic disease

Journal of African Economies

Volumn 19, Issue SUPPL. 3, 2010, Pages

  Mackintosh, Maureen ^a   Mujinja, Phares G M ^b  

^a OPEN UNIVERSITY   (United Kingdom)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

COMMODITY MARKET; COMPETITION (ECONOMICS); DISEASE CONTROL; HEALTH POLICY; MEDICINE; PHARMACEUTICAL INDUSTRY; POLICY STRATEGY; RETAILING;

EID: 77958614177     PISSN: 09638024     EISSN: 14643723     Source Type: Journal    
DOI: 10.1093/jae/ejq017     Document Type: Article

References (54)

1. Ackerlof, G. (1984) An Economic Theorist's Book of Tales. Cambridge: Cambridge University Press.
2. Beran, D., A. McCabe and J.S. Yudkin (2008) 'Access to Medicines vs. Access to Treatment: The Case of Type 1 Diabetes', Bulletin of the World Health Organisation, 86 (6): 648-9.
3. Braithwaite, J. and P. Drahos (2000) Global Business Regulation. Cambridge: Cambridge University Press.
4. Cameron, A., M. Ewen, D. Ross-Degnan, D. Ball and R. Laing (2008) 'Medicines Prices, Availability and Affordability in 36 Developing and Middle Income Countries: A Secondary Analysis', The Lancet (published online 1 December).
5. Chaudhuri, S., M. Mackintosh and P.G.M. Mujinja (forthcoming) 'Indian Generics Producers, Access to Essential Medicines and Local Production in Africa: An Argument with Reference to Tanzania', European Journal of Development Research.
6. Clinton Foundation (2008) Tanzania Pilot ACT Study: Report on Findings April http://www.clintonfoundation.org/what-we-do/clinton-hiv-aids-initiative/information-center-resources (accessed 18 April 2010).
7. Department for International Development (DFID) (2007) Working Together for Better Health http://www.dfid.gov.uk/pubs/files/health-strategy07.pdf (consulted 21 December 2008).
8. Everard, M. (2003) 'Access to medicines in low income countries', in M.N.G. Dukes, F.M. Haaijer-Ruskamp, C.P. de Joncheere and A.H. Rietveld (2002) Drugs and Money: Prices, Affordability and Cost Containment, 7th edn, Amsterdam: WHO and IOS Press.
9. Gilson, L. (2003) 'Trust and the Development of Health Care as a Social Institution', Social Science and Medicine, 53: 1457-68.
10. Government of Nigeria (2006) Medicine Prices in Nigeria Federal Ministry of Health www.haiweb.org (downloaded 14. August 2008).
11. Grabowsi, D.C. and R. Hirth (2003) 'Competitive Spillovers Across Non-profit and for Profit Nursing Homes', Journal of Health Economics, 22: 1-22.
12. Guennif, S. (2006) Industrial and Health-Related Aspects of a Global IPR Regime in Developing Countries: Case Studies from the South DIME Working Papers on Intellectual Property Rights No.7 http://ipr.dime-eu.org/ipr_publications (accessed 12 December 2008).
13. Guimier, J.-M., E. Lee and M. Grupper (2004) Processes and Issues for Improving Access to Medicines. DFID Health Systems Resource Centre (September). http://www.dfid.gov.uk/Pubs/files/dfidsynthesispaper.pdf (consulted 6 November 2008).
14. Hansmann, H. (1987) 'Economic theories of nonprofit organization', in W.W. Powell (ed.), The Nonprofit Sector: A Research Handbook, New Haven: Yale University Press.
15. Hentschel, J. (1999) 'Contextuality and Data Collection Methods: A Framework and Application to Health Service Utilisation', Journal of Development Studies, 35 (4): 64-94.
16. Kaplan, W. and R. Laing (2005) Local Production of Pharmaceuticals: Industrial Policy and Access to Medicines, HNP Discussion Paper, World Bank, Washington, DC.
17. Kowalewski, M., P.G.M. Mujinja and A. Jahn (2002) 'Can Mothers Afford Maternal Health Care Costs? Users' Costs of Maternity Services in Rural Tanzania', African Journal of Reproductive Health, 6: 1.
18. Leach, B., J.E. Palluzzi and P. Munderi (2005) Prescription for Health Development: Increasing Access to Medicines. London: Earthscan (UN Millennium Project, Task Force on HIV/AIDS, Malaria and TB, and Access to Essential Medicines), http://www.unmillenniumproject.org/reports/tf_essentialmedecines.htm downloaded 14 August 2008
19. Mackintosh, M. (2008) 'Social Enterprise as Market Regulation: Nongovernmental Interventions in Essential Medicines Wholesaling to Low Income Countries' IKD Working Paper 30 March http://www.open.ac.uk/ikd/workingpapers.shtml.
20. Mackintosh, M. and P. Tibandebage (2002) 'Inclusion by Design: Rethinking Regulatory Intervention in Tanzanian Health Care', Journal of Development Studies, 39 (1): 1-20.
21. Maïga, F.I., S. Haddad, P. Fournier and L. Gauvin (2003) 'Public and Private Sector Responses to Essential Drugs Policies: A Multilevel Analysis of Drug Prescription and Selling Practices in Mali', Social Science and Medicine, 57: 937-48.
22. Management Sciences for Health (MSH) /World Health Organisation (WHO) (2006) International Drug Price Indicator Guide. Cambridge, MA: MSH www.msh.org and http://www.who.int/medicinces/areas/access/ecofin/en/5/1/08.
23. Médicins sans Frontières (MSF) (2007)Untangling theWeb 10th Edition September http://www.msf.org/source/access/2007/Untangling_the_Web_10th_ed_2007.pdf (consulted 14 September 2008).
24. Mendis, S., K. Fukino, A. Cameron, R. Laing, A. Felipe Jr., O. Khatib, J. Leowski and M. Ewen (2007) 'The Availability and Affordability of Selected Essential Medicines for Chronic Diseases in Six Low- and Middle-Income Countries', Bulletin of the World Health Organization, 85: 279-88.
25. Ministry of Health and Ghana Health Service (n.d.) Medicine Prices in Ghana: A Comparative Study of Government, Private and Mission Sector Medicine Prices, Accra, Ghana http://www.haiweb.org/medicineprices/surveys/200410GH/sdocs/Ghana.pdf (downloaded 19 August 2008)
26. National Bureau of Statistics (NBS), Macro International (2007) Tanzania Service Provision Assessment Survey 2006. Dar es Salaam, Tanzania/Maryland, USA: NBS.
27. O'Donnell, O., E. van Doorslaer, R.P. Rannan-Eliya, A. Somanathan, S.R. Adhikari, B. Akkazieva, D. Harbianto, C.C. Garg, P. Hanvoravongchai, A.N. Herrin, M.N. Huq, S. Ibragimova, A. Karan, S.-M. Kwon, G.M. Leung, J.-F. Rachel Lu, Y. Ohkusa, B.R. Pande, R. Racelis, K. Tin, K. Tisayaticom, L. Trisnantoro, Q. Wan, B.-M. Yang and Y. Zhao (2005) Who Pays for Health Care in Asia? EQUITAP Project Working Paper No 1 www.equitap.org accessed 24 October 2006.
28. Osewe, P.L., Y.K. Nkrumah and E. Sackey (2008) Improving Access to HIV/AIDS Medicines in Africa: Trade-Related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization. Washington, DC: World Bank.
29. Republic of Kenya (2007) Medicine Price Monitor, Ministry of Health January www.haiweb.org (downloaded 12 August 2008).
30. Republic of Kenya (n.d.) A Survey of Medicines Prices in Kenya-2004, HAI/WHO www.haiweb.org (downloaded 14 August 2008).
31. Save the Children (2005) The Unbearable Cost of Illness: Poverty, Ill-Health And Access to Healthcare-Evidence from Lindi Rural District, Tanzania. Dar es Sallam: Save the Children.
32. Tetteh, E.K. (2007) 'Providing Affordable Essential Medicines to African Households: The Missing Policies and Institutions for Price Containment', Social Science and Medicine, 66: 569-81.
33. t'Hoen, E. (2002) 'TRIPS, Pharmaceutical Patents, and Access to Essential Medicines: A Long Way from Seattle to Doha', Chicago Journal International of Law, 3: 27-48.
34. Tibandebage, P. and M. Mackintosh (2005) 'The Market Shaping of Charges, Trust and Abuse: Health Care Transactions in Tanzania', Social Science and Medicine, 61: 1385-95.
35. Tukey, J.W. (1977) Exploratory Data Analysis. Reading, MA: Addison-Wesley.
36. Turshen, M. (1999) 'Reprivatizing Pharmaceutical Supplies in Africa', Journal of Public Health Policy, 22 (4): 198-225.
37. United Republic of Tanzania (URT) (2002) Household Budget Survey 2000/01. Dar es Salaam: National Bureau of Statistics, http://www.tanzania.go.tz/hbs/HomePage_HBS.html (downloaded 20 August 2008)
38. United Republic of Tanzania (URT) (2006) Medicine Price Monitor, Ministry of Health and Social Welfare, November-December www.haiweb.org (downloaded 2 June 2008).
39. United Republic of Tanzania (URT) (2007) Medicine Price Monitor Ministry of Health and Social Welfare, June-July www.haiweb.org (downloaded 15 August 2008).
40. United Republic of Tanzania (URT) (n.d.) Survey of the Medicines Prices in Tanzania www.haiweb.org (downloaded 10 December 2007).
41. van Doorslaer, E., O. O'Donnell, R. Rannan-Eliya, A. Somanathan, S.R. Adhikari, C.C. Garg, D. Harbianto, A.N. Herrin, M.N. Huq, S. Ibragimova, A. Karan, T.J. Lee, G.M. Leung, J.F. Lu, C.W. Ng, B.R. Pande, R. Racelis, S. Tao, K. Tin, K. Tisayaticom, L. Trisnantoro, C. Vasavid and Y. Zhao (2007) 'Catastrophic Payments for Health Care in Asia', Health Economics, 16 (11): 1159-84.
42. World Bank (2007) Healthy Development: the World Bank's Strategy for Health, Nutrition and Population Results. Washington, DC: World Bank, http://siteresources.worldbank.org (consulted 21 December 2008).
43. World Health Organisation (WHO) (2001) World Health Report 2001:Mental Health: New Understanding, New Hope. Geneva: WHO http://www.who.int/whr/previous/en/ (consulted 14 August 2008).
44. World Health Organisation (WHO) (2004a) The World Medicines Situation. Geneva: WHO http://www.who.int/medicinedocs/pdf/s6160e/s6160e.pdf (downloaded 12 August 2008).
45. World Health Organisation (WHO) (2004b) World Health Report 2004: Changing History. Geneva: WHO.
46. World Health Organisation (WHO) (2005a) World Health Report 2005: Make Every Mother and Child Count. Geneva: WHO http://www.who.int/whr/previous/en/ (consulted 14 August 2008).
47. World Health Organisation (WHO) (2005b) Preventing Chronic Diseases: AVital Investment. Geneva: WHO http://www.who.int/chp/chronic_disease_report/en/(downloaded 13 August 2008).
48. World Health Organisation (2007) Progress in the Rational Use of Medicines: Report by the Secretariat. Geneva: WHO (Sixtieth World Health Assembly 22 March A60/24) http://www.who.int/gb/ebwha/pdf_files/WHA60/A60_R16-en.pdf (consulted 8 November 2008).
49. World Health Organisation (2008a) Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector Progress Report 2008. Geneva: WHO http://www.who.int/hiv/mediacentre/2008progressreport/en/ (accessed 18 August 2008).
50. World Health Organisation (WHO) (2008b) World Health Report 2008: Primary Health Care: Now More than Ever. Geneva: WHO www.who.int (downloaded 6 November 2008).
51. World Health Organization/Health Action International (WHO/HAI) (2003) Medicines Prices: A New Approach to Measurement. World Health Organization and Health Action International, available at www.haiweb.org (downloaded September 2006).
52. World Health Organisation/Health Action International (WHO/HAI) (2006) Price, Availability and Affordability: An International Comparison of Chronic Disease Medicines. Cairo: WHO, Regional Office for the Eastern Mediterranean, http://www.who.int/medicines/publications/PriceAvailAfordability.pdf (downloaded 14 August 2008).
53. World Trade Organization (WTO) (1995) Agreement on Trade-Related Aspects of Intellectual Property Rights. Geneva: WTO http://www.wto.org/english/docs_e/legal_e/27-trips.pdf (accessed 12 December 2009).
54. Xu, K., D.E. Evans, P. Kadama, J. Nabyonga, P. Ogwal, P. Nabukhonzo and A.M. Aguilar (2006) 'Understanding the Impact of Eliminating User Fees: Utilization and Catastrophic Health Expenditures in Uganda', Social Science and Medicine, 62 (4): 866-76.